TY - JOUR AU - Moon, Sohee AU - Kim, Sujin AU - Mankhong, Sakulrat AU - Choi, Seong Hye AU - Vandijck, Manu AU - Kostanjevecki, Vesna AU - Jeong, Jee Hyang AU - Yoon, Soo Jin AU - Park, Kyung Won AU - Kim, Eun-Joo AU - Yoon, Bora AU - Kim, Hee Jin AU - Jang, Jae-Won AU - Hong, Jin Yong AU - Park, Dong-Ho AU - Shaw, Leslie M. AU - Kang, Ju-Hee PY - 2021 DA - 2021/01/12 TI - Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans JO - Alzheimer's Research & Therapy SP - 22 VL - 13 IS - 1 AB - Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker cutoffs from immunoassays with low interlaboratory variability in diverse ethnic groups are necessary for their use in clinics and clinical trials. With lack of cutoffs from fully automated immunoassay platforms in diverse races, the aim of this study is to evaluate the clinical utility of CSF AD biomarkers from the Lumipulse fully automated immunoassay based on β-amyloid (Aβ) positron emission tomography (PET) status comparing with these from two manual immunoassays, in Koreans. SN - 1758-9193 UR - https://doi.org/10.1186/s13195-020-00767-3 DO - 10.1186/s13195-020-00767-3 ID - Moon2021 ER -